Lonza Shares Rise on Sales, Earnings Beat
By David Sachs
Lonza shares jumped Friday after the company posted consensus-beating sales and earnings.
At 0858 GMT, shares in the Swiss life-sciences company were up 13% at CHF419.30 after rising as high as CHF420.90.
Lonza's full-year sales of 6.72 billion Swiss francs ($7.75 billion) were 3% above the company-compiled consensus, while core earnings before interest, taxes, depreciation and amortization were 5% ahead at CHF2.00 billion, Jefferies analysts said in a note.
Jefferies said the stronger second half of last year should offset negative currency affects and could trigger small consensus updates, which is better than the downside risk feared by the analysts.
Lonza also nominated Jean-Marc Huet to replace Albert Baehny as chairman, but the move shouldn't disrupt the group's crucial search for a new chief executive, Jefferies said.
Write to David Sachs at david.sachs@wsj.com
(END) Dow Jones Newswires
January 26, 2024 04:23 ET (09:23 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks